New recommendations from the 2024 ESC Guidelines on CCS for INOCA/ANOCA 🔝. @secardiologia@shci_sec@JEscaned@ramonlopezpalop@fer_iver@belcid7@ErnestoValero84
🥇Coronary función test (CFT) to identify INOCA/ANOCA endotypes: IB
🥈Medical treatment guided by CFT: IIa.
🥉Angina in HFpEF with unobstructred CAD, rule out MVD: IIa.
🎯Definition of endotypes and Specific treatment recommendations
Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B.
This represent a paradigm shift in the diagnosis and treatment of these patients.
⚡️Big News w/ #ESCGuidelines OCT-guided PCI & assessing patients for CMD now @ Class 1A & 1B
Abbott leads the way w/ unique solutions to improve patient outcomes
AI-driven #Ultreon for OCT
PressureWire X & CoroFlow for INOCA/ANOCA patients
Safety Info: https://t.co/79Sc3I3skc
Happening NOW in the #EuroPCR Training Village.
Great to see physicians honing their skills with our AI-driven #IntravascularImaging and exploring the features of our orbital atherectomy technology.
#CardioTwitter
Large network meta-analysis shared in @theLancet https://t.co/92wUrcg1qL showed for the first time reductions in clinical events demonstrating safety & effectiveness of image-guided PCI
⬇️25% all-cause death
⬇️17% MI
⬇️48% ST
⬇️28% repeat TVR
Safety Info: https://t.co/5IuGQfdcMu
📰 Late-breaking data at #CRT2024: XIENCE #Stent showed strong performance in patients with single-layer ISR at 1-year: ¹
• 0% cardiac death
• 0.4% all cause death
• 1.2% ST
Learn more & safety Info: https://t.co/qdAGM8V0Rk
Join us during ACI 2024 in London on 1/31 from 6-8pm at the Hilton Metropole London, UL. Discover the future of cardiac care with HeartFlow’s interactive session on CCTA+FFRCT at BCIS ACI 2024. Register here: https://t.co/t4UDeS3YTf.
@NickCurzen@ColletCarlos@BCIS_uk
I curso de Calcio-OCT en HJRJ, Huelva. La formación, la base para abordar las lesiones coronarias mas complejas guiadas por OCT, buscando la excelencia con grandes AMIGOS EXPERTOS. @cardiojsl @AJuradoRoman @CamachoFreire@ElenaIzaga @OscarLa81605851 @Albabfc
Aun quedan plazas libres para asistir al curso de MINOCA el 2/2/24 en BCN. Expertos nacionales e internacionales nos mostraran los algoritmos diagnosticos para este dx de trabajo y sus causas con la presentacion de 6 casos clinicos. No te lo pierdas! Link: https://t.co/8wyTVJkGsi
Get a demo of our latest Ultreon 2.0 Software for #OCTimaging at #TCT2023 at Abbott’s booth.
➡️ Sign up to get more info: https://t.co/ysXCKyjJju
#imagefirst
Safety Info: https://t.co/YhSeYUtxzF
From the latest #OCTimaging clinical data at #ESC2023 to the latest imaging solution—Ultreon 2.0 Software, our AI-enabled IVI software.
3⃣top reasons why you should consider Ultreon Software for your complex PCI.
#imagefirst
Safety Info: https://t.co/YhSeYUtxzF
1/5
It’s finally OCT-ober 🎃 our special time of the year to highlight 🔑 info about #OCTimaging 💡 for PCI guidance.
This year there’s a lot of new of imaging data post #ESC2023. So let’s dive in, #CardioTwitter. ⬇️
Safety Info: https://t.co/Kt8XiEb8QG
🧵 1/8
Optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the two-year rate of target vessel failure compared with angiography-guided #PCI ⬇️
#ESCCongress ILUMIEN IV trial
Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided #PCI ⬇️
#ESCCongress OCT vs. IVUS vs. Angiography Guidance; a real-time updated network meta-analysis